|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/4745 | (2006.01) |
| A61K 31/4245 | (2006.01) | ||
| A61K 31/41 | (2006.01) | ||
| C07D 271/07 | (2006.01) | ||
| C07D 257/04 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 35/04 | (2006.01) |
| (11) | Number of the document | 3622953 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19205104.3 |
| Date of filing the European patent application | 2017-05-17 | |
| (97) | Date of publication of the European application | 2020-03-18 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-17 |
| (46) | Date of publication of the claims translation | 2021-04-26 |
| (30) | Number | Date | Country code |
| PA201670325 | 2016-05-17 | DK |
| (72) |
Brünner, Nils Aage, DK
Christophersen, Palle, DK
Stenvang, Jan, DK
Lichtenberg, Jens, DK
Thougaard, Annemette, DK
|
| (73) |
Scandion Oncology A/S,
Fruebjergvej 3, 2100 Copenhagen,
DK
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kombinuotas vėžio gydymas |
| COMBINATION TREATMENT OF CANCER |
| Payment date | Validity (years) | Amount | |
| 2022-05-02 | 6 | 139.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-05-17 |